1-6 of 6
Rupal Desai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors – Efficacy, Safety, and Biomarker Results

Geoffrey J. Lindeman, Tharu M. Fernando, Rebecca Bowen, Katarzyna J. Jerzak, Xinni Song, Thomas Decker, Frances Boyle, Steve McCune, Anne Armstrong, Catherine Shannon, Gianfilippo Bertelli, Ching-Wei Chang, Rupal Desai, Kushagra Gupta, Timothy R. Wilson, Aulde Flechais, Aditya Bardia
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (15): 3256–3267.
https://doi.org/10.1158/1078-0432.CCR-21-3811
Published: 02 August 2022
View article titled, VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors – Efficacy, Safety, and Biomarker Results
Open the PDF for VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors – Efficacy, Safety, and Biomarker Results in another window
Includes: Supplementary data
Journal Articles

Abstract POSTER-THER-1441: Biomarker evaluation of phase 1 clinical trials of antibody-drug conjugates (ADCs) in platinum resistant ovarian cancer

Yulei Wang, Ron Firestein, Lisa Ryner, Walter Darbonne, Yinghui Guan, Shan Lu, YJ Choi, Yuanyuan Xiao, Paul Polakis, Becky Suttmann, Rupal Desai, Ling Fu, Ola Saad, Kirsten Achilles Poon, Mitch Denker, Vincent Leveque, Teiko Sumiyoshi, Mark Lackner, David Shames, Eric Humke, Daniel Mayslar
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (16_Supplement): POSTER-THER-1441.
https://doi.org/10.1158/1557-3265.OVCASYMP14-POSTER-THER-1441
Published: 15 August 2015
View article titled, Abstract POSTER-THER-1441: Biomarker evaluation of phase 1 clinical trials of antibody-drug conjugates (ADCs) in platinum resistant ovarian cancer
Journal Articles

An Antibody–Drug Conjugate Directed against Lymphocyte Antigen 6 Complex, Locus E (LY6E) Provides Robust Tumor Killing in a Wide Range of Solid Tumor Malignancies

Jyoti Asundi, Lisa Crocker, Jarrod Tremayne, Peter Chang, Chie Sakanaka, Josh Tanguay, Susan Spencer, Sreedevi Chalasani, Elizabeth Luis, Karen Gascoigne, Rupal Desai, Rajiv Raja, Brad A. Friedman, Peter M. Haverty, Paul Polakis, Ron Firestein
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (14): 3252–3262.
https://doi.org/10.1158/1078-0432.CCR-15-0156
Published: 14 July 2015
View article titled, An Antibody–Drug Conjugate Directed against Lymphocyte Antigen 6 Complex, Locus E (LY6E) Provides Robust Tumor Killing in a Wide Range of Solid Tumor Malignancies
Open the PDF for An Antibody–Drug Conjugate Directed against Lymphocyte Antigen 6 Complex, Locus E (LY6E) Provides Robust Tumor Killing in a Wide Range of Solid Tumor Malignancies in another window
Includes: Supplementary data
Journal Articles

Biomarker Analyses from a Placebo-Controlled Phase II Study Evaluating Erlotinib ± Onartuzumab in Advanced Non–Small Cell Lung Cancer: MET Expression Levels Are Predictive of Patient Benefit

Hartmut Koeppen, Wei Yu, Jiping Zha, Ajay Pandita, Elicia Penuel, Linda Rangell, Rajiv Raja, Sankar Mohan, Rajesh Patel, Rupal Desai, Ling Fu, An Do, Vaishali Parab, Xiaoling Xia, Tom Januario, Sharianne G. Louie, Ellen Filvaroff, David S. Shames, Ignacio Wistuba, Marina Lipkind, Jenny Huang, Mirella Lazarov, Vanitha Ramakrishnan, Lukas Amler, See-Chun Phan, Premal Patel, Amy Peterson, Robert L. Yauch
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (17): 4488–4498.
https://doi.org/10.1158/1078-0432.CCR-13-1836
Published: 01 September 2014
View article titled, Biomarker Analyses from a Placebo-Controlled Phase II Study Evaluating Erlotinib ± Onartuzumab in Advanced Non–Small Cell Lung Cancer: MET Expression Levels Are Predictive of Patient Benefit
Open the PDF for Biomarker Analyses from a Placebo-Controlled Phase II Study Evaluating Erlotinib ± Onartuzumab in Advanced Non–Small Cell Lung Cancer: MET Expression Levels Are Predictive of Patient Benefit in another window
Includes: Supplementary data
Journal Articles

A novel method for mutation analyses using genomic DNA obtained from IHC-stained sections

Rupal Desai, Lukas Amler, Rajesh Patel, Howard Stern, Rajiv Raja
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (19_Supplement): B34.
https://doi.org/10.1158/DIAG-10-B34
Published: 15 August 2014
View article titled, A novel method for mutation analyses using genomic DNA obtained from IHC-stained sections
Journal Articles

Optimization of a method for preserving nucleic acids in tissue lysates from archival formalin-fixed tissue samples

Ling Fu, Rupal Desai, Thomas Holcomb, Rajiv Raja
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (19_Supplement): B35.
https://doi.org/10.1158/DIAG-10-B35
Published: 15 August 2014
View article titled, Optimization of a method for preserving nucleic acids in tissue lysates from archival formalin-fixed tissue samples